| A novel telomere structure in a human alternative lengthening of telomeres cell line. | |
| | |
MedLine Citation:
|
PMID: 15805272 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Cancer cells require mechanisms to maintain telomeres. Most use telomerase, but 5% to 20% of tumors use alternative lengthening of telomeres (ALT), a telomerase-independent mechanism that seems to depend on recombination. ALT is characterized by amplification of telomere TTAGGG repeats to lengths beyond 50 kb, by elevated rates of telomere recombination, and by nuclear structures called ALT-associated promyelocytic leukemia bodies. In Saccharomyces cerevisiae, survivors of telomerase inactivation also use recombination to maintain telomeres. There are two types of survivors, which differ in telomere structure. The first possesses telomere repeats and the Y' subtelomeric element amplified together as a tandem array at chromosome termini (type I), and the other possesses amplification of telomeric repeats alone (type II), similar to previously described human ALT cells. Here, we describe the first human ALT cell line having "tandem array" telomeres with a structure similar to that of type I yeast survivors. The chromosome termini consist of a repeat unit containing approximately 2.5 kb of SV40 DNA and a variable amount of TTAGGG sequence repeated in tandem an average of 10 to 20 times. Similar to previously described ALT cells, they show evidence of telomere recombination, but unlike standard ALT cells, they lack ALT-associated promyelocytic leukemia bodies and their telomeres are transcribed. These findings have implications for the pathogenesis and diagnosis of cancer. |
| | |
Authors:
|
Robert A Marciniak; David Cavazos; Richard Montellano; Qijun Chen; Leonard Guarente; F Brad Johnson |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. |
Journal Detail:
|
Title: Cancer research Volume: 65 ISSN: 0008-5472 ISO Abbreviation: Cancer Res. Publication Date: 2005 Apr |
Date Detail:
|
Created Date: 2005-04-04 Completed Date: 2005-05-26 Revised Date: 2007-11-14 |
Medline Journal Info:
|
Nlm Unique ID: 2984705R Medline TA: Cancer Res Country: United States |
Other Details:
|
Languages: eng Pagination: 2730-7 Citation Subset: IM |
Affiliation:
|
Department of Medicine, University of Texas Health Science Center at San Antonio, South Texas Veterans Health Care System, San Antonio, Texas 78229-3900, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Base Sequence Cell Line DNA / genetics, metabolism Fibroblasts / cytology Hela Cells Humans Leukemia, Promyelocytic, Acute / genetics Molecular Sequence Data Repetitive Sequences, Nucleic Acid Simian virus 40 / genetics* Telomere / genetics*, metabolism Transcription, Genetic |
| Grant Support | |
ID/Acronym/Agency:
|
K08AG000775/AG/NIA NIH HHS |
| Chemical | |
Reg. No./Substance:
|
9007-49-2/DNA |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Telomerase-independent telomere length maintenance in the absence of alternative lengthening of telo...
Next Document: Broad-spectrum G protein-coupled receptor antagonist, [D-Arg1,D-Trp5,7,9,Leu11]SP: a dual inhibitor ...